VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume

VanEck Pharmaceutical ETF (NASDAQ:PPH) saw unusually-strong trading volume on Monday . Approximately 137,325 shares changed hands during trading, an increase of 4% from the previous session’s volume of 132,308 shares.The stock last traded at $87.21 and had previously closed at $86.80.

VanEck Pharmaceutical ETF Price Performance

The company has a market cap of $502.59 million, a PE ratio of 20.57 and a beta of 0.72. The business has a 50-day moving average of $88.60 and a 200 day moving average of $83.77.

VanEck Pharmaceutical ETF Dividend Announcement

The company also recently disclosed a dividend, which was paid on Friday, April 5th. Investors of record on Tuesday, April 2nd were given a dividend of $0.5328 per share. The ex-dividend date was Monday, April 1st.

Institutional Trading of VanEck Pharmaceutical ETF

Hedge funds have recently bought and sold shares of the company. Allworth Financial LP purchased a new stake in VanEck Pharmaceutical ETF during the fourth quarter valued at $28,000. Global Retirement Partners LLC increased its position in VanEck Pharmaceutical ETF by 2,343.8% during the first quarter. Global Retirement Partners LLC now owns 391 shares of the company’s stock valued at $35,000 after acquiring an additional 375 shares during the last quarter. Cary Street Partners Investment Advisory LLC purchased a new stake in VanEck Pharmaceutical ETF during the third quarter valued at $60,000. CoreFirst Bank & Trust purchased a new stake in VanEck Pharmaceutical ETF in the third quarter worth about $76,000. Finally, Assetmark Inc. purchased a new stake in VanEck Pharmaceutical ETF in the third quarter worth about $211,000.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.